How 'killer' T cells could boost COVID immunity in face of new variants.

Ledford, Heidi

Ledford, Heidi.

Nature ; 590(7846): 374-375, 2021 02.

Article in English | MEDLINE | ID: covidwho-1099313

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/immunology; COVID-19/virology; Cytotoxicity, Immunologic; SARS-CoV-2/classification; SARS-CoV-2/immunology; T-Lymphocytes/immunology; Antibodies, Neutralizing/analysis; Antibodies, Neutralizing/immunology; COVID-19/prevention & control; Drug Industry; Humans; Immunologic Memory; SARS-CoV-2/chemistry; SARS-CoV-2/genetics; Spike Glycoprotein, Coronavirus/chemistry; Spike Glycoprotein, Coronavirus/genetics; Spike Glycoprotein, Coronavirus/immunology; Uncertainty; Virus Shedding/immunology

Keywords

Immunology; SARS-CoV-2; Vaccines; Virology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: T-Lymphocytes / Cytotoxicity, Immunologic / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Nature Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google